Pierre Rybarczyk
Overview
Explore the profile of Pierre Rybarczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caillard P, Bennis Y, Boudot C, Chatelain D, Rybarczyk P, Boullier A, et al.
Ren Fail
. 2024 Oct;
46(2):2415510.
PMID: 39422224
Acute kidney injury (AKI) and chronic kidney disease (CKD) are major health concerns due to their increasing incidence and high mortality. They are interconnected syndromes; AKI without recovery evolves into...
2.
Schnipper J, Kouba S, Hague F, Girault A, Rybarczyk P, Telliez M, et al.
Int J Mol Sci
. 2022 Jul;
23(14).
PMID: 35887266
Dysregulation of the transient receptor canonical ion channel (TRPC1) has been found in several cancer types, yet the underlying molecular mechanisms through which TRPC1 impacts pancreatic ductal adenocarcinoma (PDAC) cell...
3.
Foulon A, Rybarczyk P, Jonckheere N, Brabencova E, Sevestre H, Ouadid-Ahidouch H, et al.
Int J Mol Sci
. 2022 Mar;
23(6).
PMID: 35328381
Breast cancer is the leading cause of cancer death among women in worldwide and France. The disease prognosis and treatment differ from one breast cancer subtype to another, and the...
4.
Raab S, Very N, Duchene B, Rybarczyk P, Jonckheere N, El Yazidi-Belkoura I, et al.
Oncol Lett
. 2022 Mar;
23(4):105.
PMID: 35242233
Tumor occurrence and development are closely related to metabolism abnormalities. One of the metabolic networks that is dysregulated during carcinogenesis is the fatty acid synthesis pathway, which is mainly controlled...
5.
Auwercx J, Rybarczyk P, Kischel P, Dhennin-Duthille I, Chatelain D, Sevestre H, et al.
Nutrients
. 2021 Jan;
13(1).
PMID: 33450887
Despite magnesium (Mg) representing the second most abundant cation in the cell, its role in cellular physiology and pathology is far from being elucidated. Mg homeostasis is regulated by Mg...
6.
Lefebvre T, Rybarczyk P, Bretaudeau C, Vanlaeys A, Cousin R, Brassart-Pasco S, et al.
Front Cell Dev Biol
. 2020 Aug;
8:549.
PMID: 32733880
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy with a very poor prognosis due to highly metastatic profile. Cell migration is an essential step of the metastatic cascade allowing cancer cells...
7.
Vanlaeys A, Fouquet G, Kischel P, Hague F, Pasco-Brassart S, Lefebvre T, et al.
Arch Toxicol
. 2020 Feb;
94(3):735-747.
PMID: 32080757
Cadmium is a xenobiotic involved in neoplastic transformation. Cadmium enters the cells through divalent cation transporters including the Transient Receptor Potential Melastatin-related 7 (TRPM7) which is known to be involved...
8.
Kischel P, Girault A, Rodat-Despoix L, Chamlali M, Radoslavova S, Abou Daya H, et al.
Cancers (Basel)
. 2019 Mar;
11(3).
PMID: 30884858
In the battle against cancer cells, therapeutic modalities are drastically limited by intrinsic or acquired drug resistance. Resistance to therapy is not only common, but expected: if systemic agents used...
9.
Rybarczyk P, Vanlaeys A, Brassart B, Dhennin-Duthille I, Chatelain D, Sevestre H, et al.
Neoplasia
. 2017 Mar;
19(4):288-300.
PMID: 28284058
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a very poor prognosis. There is an urgent need to better understand the molecular mechanisms that regulate PDAC cell aggressiveness. The...
10.
Rybarczyk P, Gautier M, Hague F, Dhennin-Duthille I, Chatelain D, Kerr-Conte J, et al.
Int J Cancer
. 2012 Feb;
131(6):E851-61.
PMID: 22323115
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive forms of cancer with a tendency to invade surrounding healthy tissues, leading to a largely incurable disease. Despite many advances...